Cultural variations of coping strategies and quality of life among women with breast cancer undergoing chemotherapy during COVID-19: A two-country cross-sectional study
Cultural variations of coping strategies and quality of life among women with breast cancer undergoing chemotherapy during COVID-19: A two-country cross-sectional study
Connection, shared experience and practical learning sit at the heart of CNSA’s Communities of Practice. In April, a record six CoPs came together, creating space for cancer nurses across the country to exchange insights, explore emerging challenges and learn from one another in a supportive, peer-led environment.
Catch up on key insights about the most common side effects of breast cancer treatment—and why early referral to Allied Health can make all the difference. Learn practical tips to support better recovery and long‑term wellbeing.
A new targeted oral therapy is changing the landscape for people with hormone receptor positive, HER2 negative metastatic breast cancer, offering another option for those whose disease has progressed on prior treatment. This practical session will step through how the treatment works, when it is used and what makes its side effect profile distinct.
Last week saw an exciting development for Cancer Nurse Practitioners, who are now authorised to prescribe an expanded list of oncology and haematology medicines listed on the PBS General Schedule, further strengthening their ability to deliver timely, comprehensive cancer care.
Australia now has clarity it has never had before: 20,950 Australians are living with metastatic breast cancer — more than double what was previously understood. This new national estimate exposes decades of undercounting, underestimated need, and under-resourced care.
Don't miss out on our next Rare Cancers CoP meeting with respected bioethicist and public health scientist, Dr Evie Kendall, as she uncovers Challenging Conversations in Unfunded Therapy.
